MARKET

GLPGF

GLPGF

Galapagos
OTCPK
64.00
NaN%
Closed 09:30 04/01 EDT
OPEN
--
PREV CLOSE
48.70
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
64.00
52 WEEK LOW
64.00
MARKET CAP
4.22B
P/E (TTM)
11.20
1D
5D
1M
3M
1Y
5Y
1D
Galapagos NV, Gilead Sciences strike deal tied to Ouro Medicines acquisition
Seeking Alpha · 2d ago
Tracking David Einhorn's Greenlight Capital Portfolio - Q4 2025 Update
Seeking Alpha · 03/23 00:09
Galapagos GAAP EPS of €4.87, revenue of €1.11B; introduces Q1 and FY26 outlook
Seeking Alpha · 02/24 04:32
Galapagos: Pivoting From Clinical Risk To Strategic Capital Allocation
Seeking Alpha · 12/22/2025 10:39
Tracking David Einhorn's Greenlight Capital Portfolio - Q3 2025 Update
Seeking Alpha · 12/15/2025 04:48
Tracking David Einhorn's Greenlight Capital Portfolio - Q2 2025 Update
Seeking Alpha · 09/23/2025 01:09
Weekly Report: what happened at GLPGF last week (0908-0912)?
Weekly Report · 09/15/2025 11:27
Weekly Report: what happened at GLPGF last week (0901-0905)?
Weekly Report · 09/08/2025 11:30
More
About GLPGF
Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is engaged in the discovery and development of small molecule medicines with modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications. The Company focuses on developing a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. It develops transformational medicines in areas of high unmet need by combining internal with external science with the goal to add years of life and improve of life of patients across the globe. It discovers which proteins that are involved in causing diseases such as, rheumatoid, arthritis, inflammatory bowel disease and fibrosis. The Company acquired CellPoint and AboundBio in order to develop a cell therapy, which is a potential transformative treatment of different types of cancer.

Webull offers Galapagos NV stock information, including OTCPK: GLPGF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GLPGF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GLPGF stock methods without spending real money on the virtual paper trading platform.